13-107866104-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001080396.3(NALF1):āc.493G>Cā(p.Val165Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000242 in 1,612,878 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001080396.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NALF1 | NM_001080396.3 | c.493G>C | p.Val165Leu | missense_variant | 1/3 | ENST00000375915.4 | NP_001073865.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NALF1 | ENST00000375915.4 | c.493G>C | p.Val165Leu | missense_variant | 1/3 | 1 | NM_001080396.3 | ENSP00000365080 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000203 AC: 5AN: 246888Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134718
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1460584Hom.: 0 Cov.: 33 AF XY: 0.00000963 AC XY: 7AN XY: 726570
GnomAD4 genome AF: 0.000125 AC: 19AN: 152294Hom.: 0 Cov.: 32 AF XY: 0.000175 AC XY: 13AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 22, 2022 | The c.493G>C (p.V165L) alteration is located in exon 1 (coding exon 1) of the FAM155A gene. This alteration results from a G to C substitution at nucleotide position 493, causing the valine (V) at amino acid position 165 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at